IMM 1.45% 34.0¢ immutep limited

dendritic cell vaccine increases survival

  1. 212 Posts.
    An interesting read that I believe no one has posted on hot copper. The article reports a high success rate using the same process that CVAC is using, but this article is about brain cancer.

    Trials are proving the therapy works across a range of different cancers, with PRR at the forefront of an ovarian cancer treatment.

    http://www.healthmagdaily.com/personlized-dendritic-cell-vaccine-increases-survival-in-patients-with-deadly-brain-cancer.html
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.